Novel kinase inhibitors afuresertib and pim447 are active in a predictive myeloma in vivo model, and a crispr genome-wide screening approach identifies biomarkers determining susceptibility / Keane, N.; Sharik, M.; Natoni, A.; Chesi, M.; Bergsagel, L.; Michael, O.. - In: HEMASPHERE. - ISSN 2572-9241. - 2:Supplement 1(2018), pp. 1-1113. [10.1097/HS9.0000000000000060]
Novel kinase inhibitors afuresertib and pim447 are active in a predictive myeloma in vivo model, and a crispr genome-wide screening approach identifies biomarkers determining susceptibility
A. NatoniInvestigation
;
2018
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
